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Detailed visualization of microvascular changes in the human retina
is clinically limited by the capabilities of angiography imaging, a
2D fundus photograph that requires an intravenous injection of
ﬂuorescent dye. Whereas current angiography methods enable
visualization of some retinal capillary detail, they do not ade-
quately reveal the choriocapillaris or other microvascular features
beneath the retina. We have developed a noninvasive microvas-
cular imaging technique called phase-variance optical coherence
tomography (pvOCT), which identiﬁes vasculature three dimen-
sionally through analysis of data acquired with OCT systems. The
pvOCT imaging method is not only capable of generating capillary
perfusion maps for the retina, but it can also use the 3D capabilities
to segment the data in depth to isolate vasculature in different
layers of the retina and choroid. This paper demonstrates some of
the capabilities of pvOCT imaging of the anterior layers of
choroidal vasculature of a healthy normal eye as well as of eyes
with geographic atrophy (GA) secondary to age-related macular
degeneration. The pvOCT data presented permit digital segmenta-
tion to produce 2D depth-resolved images of the retinal vascula-
ture, the choriocapillaris, and the vessels in Sattler’s and Haller’s
layers. Comparisons are presented between en face projections of
pvOCT data within the superﬁcial choroid and clinical angiography
images for regions of GA. Abnormalities and vascular dropout ob-
served within the choriocapillaris for pvOCT are compared with
regional GA progression. The capability of pvOCT imaging of the
microvasculature of the choriocapillaris and the anterior choroi-
dal vasculature has the potential to become a unique tool to
evaluate therapies and understand the underlying mechanisms
of age-related macular degeneration progression.
ocular circulation | ocular vasculature | optical angiography |
ophthalmic imaging | Fourier-domain optical coherence tomography
Current clinical evaluation of outer retinal disease progressionis accomplished with multiple imaging modalities including
fundus photography, ﬂuorescein angiography (FA), indocyanine
green angiography (ICGA), fundus autoﬂuorescence (FAF), and
near infrared autoﬂuorescence (1, 2). Whereas angiography
techniques are ideal to observe retinal and choroidal circulation,
the lack of depth selectivity limits the ability to observe micro-
vasculature in the choriocapillaris (CC) and the anterior choroid.
FA is typically limited to retinal vasculature due to light ab-
sorption by the retinal pigment epithelial (RPE) cells and leakage
of ﬂuorescein from the choriocapillaris, whereas ICGA primarily
images only the larger choroidal vessels. The development of
a unique noninvasive method for visualizing changes in the RPE
layer and CC with high resolution could advance our un-
derstanding of disease progression and invites unique oppor-
tunities for early diagnosis, timely treatment, and evaluating
potential therapeutics.
One of the major applications of noninvasive choroidal
imaging is for late stages of age-related macular degeneration
(AMD), the leading cause of central visual loss and legal
blindness in Americans 65 y of age and older (3). Geographic
atrophy (GA), one of the common features of AMD, involves
the progressive loss of the retinal photoreceptors and the RPE
cells, as well as atrophy of the underlying CC and choroidal
vessels (4–6). GA regional identiﬁcation is typically accomplished
using autoﬂuorescence imaging techniques, which depend on
lipofuscin accumulation within RPE cells associated with this
disease, but the current clinical imaging methods are limited in
detecting early morphological changes in the choriocapillaris
(7, 8). An improved understanding of the progression of GA
and its underlying mechanisms is important to develop potential
therapeutic targets for intervention, and diagnostic tools capable
of observing the key features of atrophic AMD are critical for
fulﬁlling this goal.
Optical coherence tomography (OCT) is a noninvasive clinical
diagnostic tool that performs high-resolution (few micrometers),
3D cross-sectional imaging of the retina (9, 10). Current OCT
imaging provides detailed retinal morphology that correlates
well with histologic ﬁndings. Although high-resolution OCT is
capable of depicting structural alterations of the outer retinal
layers including the RPE layer in patients with atrophic AMD
(11), conventional OCT imaging provides limited visualization of
the retinal and choroidal circulation. Recently, the enhanced
depth imaging technique demonstrated cross-sectional images of
choriocapillaris and larger choroidal vessels with improved OCT
sensitivity in the choroid to measure choroidal thickness (12, 13).
To image retinal and choroidal vasculature noninvasively, we
have developed phase-variance optical coherence tomography
(pvOCT), which calculates contrast based on the motion ob-
served over time of the 3D OCT data. This additional contrast
method allows for in vivo visualization of volumetric morphology
of retinal and choroidal microvasculature with high sensitivity
as well as presentation of the vascular data in the form of depth-
encoded 2D perfusion maps of the retina. A principal beneﬁt of
pvOCT for translational research and further clinical applica-
tions is that this is a data analysis technique that can be adapted
for use by clinically available OCT systems without requiring any
hardware modiﬁcations. Composite imaging of conventional
OCT intensity images and pvOCT images highlights localiza-
tion of vascular changes in three dimensions, which may allow
for more accurate diagnosis of changes in CC that may lead to
GA. In addition, disruptions in the photoreceptors and RPE
that may be associated with these vascular changes can also be
studied simultaneously.
Results
We acquired OCT volumetric data of the macula (posterior ret-
ina) of a normal human subject and one AMD patient with GA.
Using a custom-built Fourier-domain OCT (Fd-OCT) system, we
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performedpvOCT imaging scans over retinal areas of 1.5× 1.5mm2
and3× 3mm2with an acquisition time of 3.6 s in addition to scans
of 1.5 × 3 mm2 and 3 × 1.5 mm2 acquired in 6.9 s. Healthy retinal
areas at the macula and the peripheral retina were imaged for
comparison with atrophic areas in AMD. The pvOCT images
were created using postprocessing procedures including phase-
variance–based analysis to identify motion contrast as well as
segmentation of the 3D data for visualizing vasculature both in
the retina and the choroid. Details of the phase-variance pro-
cessing and visualization for pvOCT are described in Fig. S1.
Microcirculation in the Retina and the Choroid. Fundus FA has
served as the gold standard for imaging the retinal vasculature and
its abnormalities, including but not limited to microaneurysms,
capillary nonperfusion, and neovascularization. In addition,
fundus ICGA has been mainly used to identify choroidal vascular
abnormalities, although it visualizes both retinal and choroidal
circulation. Unlike FA, the absorption (∼790–800 nm) and
emission (∼830–840 nm) wavelengths of ICGA are in the near-
infrared range, which enables imaging deep choroidal networks
below the RPE. By zooming in on fundus FA and ICGA of
a 60-y-old male subject with no previous history of ocular dis-
ease, vascular networks in the retina (Fig. 1A) as well as in the
retina and the choroid (Fig. 1B) are observed (viewable full size
images in Fig. S2). However, these clinical imaging modalities are
limited in their ability to visualize the CC, which provides the
blood supply to the photoreceptors and may be damaged as AMD
progresses. One major difﬁculty in studying the changes in CC
has been its anatomical location below the photoreceptors and
the highly pigmented RPE, where most of the incident light is
absorbed or scattered. The CC consists of lobules of fenestrated
capillary plexus in the macula. These features make CC difﬁcult
to visualize by FA and ICGA.
Our OCT angiographic technique, pvOCT, allows in vivo
visualization of the retinal and choroidal circulation with depth
information. The cross-sectional composite image (Fig. 1C)
scanned at the retinal location identiﬁed by the yellow dashed
line in Fig. 1A emphasizes vascular depth information (red)
available in the retina and the choroid. This cross-sectional
(B-scan) image was a combination of the standard Fd-OCT
B-scan (Fig. S3A) and the phase variance processed contrast
for the same location (Fig. S3B). An en face projection of the
pvOCT volumetric data (Movie S1) enables visualization of
capillary perfusion maps of different posterior layers. The retinal
vasculature (Fig. 1D) was segmented from the retinal nerve ﬁber
layer to the outer plexiform layer (yellow dashed rectangle in
Fig. S3C). The diameter of the smallest retinal capillaries im-
aged in Fig. 1D is ∼5–10 μm. In the choroid, there are three
layers shown in Fig. S3A: the CC underneath Bruch’s mem-
brane, Sattler’s layer containing medium-sized choroidal ves-
sels, and Haller’s layer containing large choroidal vessels and
pigmented cells. The CC imaging (Fig. 1E) was segmented as
a thin depth slice located ∼5.2 μm underneath Bruch’s mem-
brane (marked by the green dotted rectangle in Fig. S3C). The
resolved size of CC in Fig. 1E is ∼20 μm in diameter. Con-
tained within the motion contrast of the lobular capillary plexus
are retinal vessel shadow artifacts marked by yellow arrows (Fig.
1C), which are caused by imaging below regions of ﬂow with
remaining nonzero phase-variance values. As indicated by the
green arrowheads (Fig. 1C), there is no phase-variance signal
inside deep choroidal vessels, whereas the signal is present in
surrounding capillary plexuses outside the feeder vessels. To
visualize the choroidal vasculature (Fig. 1F), an image was
created after inversing minimum projection (Fig. S3D) of the
blue dotted rectangular area (Fig. S3C). A composite (Fig.
1G) of the retinal vasculature (Fig. 1D, red) and the CC (Fig.
1E, green) demonstrates distinct features of posterior pole CC.
In this superimposed image, some retinal vessels are coded as
yellowish instead of red because larger retinal vessels were
included in the CC image (Fig. 1E) due to the shadow artifacts
of the retinal vessels.
An additional scan was performed at the same location
(Fig. S4 A–C) to demonstrate the reproducibility of this im-
aging method. It should be noted that there appear to be var-
iations in the vascular contrast, particularly in Fig. 1E, which
present as bright and dim horizontal regions in the image. This
banding is present in the horizontal direction in both scans ac-
quired over the same region (Fig. 1 and Fig. S4), where the slow
scan direction of the 3D scan is vertical. This variation in the
phase-variance signal appears at different positions in the two
different scans but with similar spatial frequency, corresponding
to this subject’s pulse, which caused the nonuniform vascular
patterns (Fig. S4D). Similarly, the vertical banding of the vascular
contrast variations in the pvOCT projection of Fig. 2 occurred
because the primary scan direction was oriented 90° relative to
the data of Fig. 1.
Choriocapillaris and Vasculature in Sattler’s Layer. Anatomical
studies of human choroidal circulation have reported that struc-
tural patterns and sizes of CC have regional variations over the
retina (14, 15). To demonstrate in vivo CC images at different
retinal locations, we acquired pvOCT over peripheral retina
(6° nasal and 12° inferior retina eccentricities) in the left eye
(visual acuity: 20/60) of a 61-y-old female with geographic at-
rophy in the fovea. The color fundus photograph (Fig. 2A)
shows no major degeneration in the acquired region denoted
by the yellow dotted rectangle in Fig. S5A. Highly anastomosed
capillary networks (Fig. 2C) in CC are included in the ﬂy-
Fig. 1. Comparison of fundus photographs and pvOCT en face projection
images for a scanning area of 1.5 × 3 mm2. Selected regions of FA (A) and
ICGA (B) of a healthy volunteer from large ﬁeld photographs (Fig. S2). The
cross-sectional composite depth image (C) of OCT intensity (gray) and pvOCT
(red) is presented for the retinal location identiﬁed by the yellow dashed line
in A. En face maximum projection of pvOCT data segmented from retinal
layers and at a depth of 5.2 μm underneath Bruch’s membrane, to present
the features of the retinal vessels (D) and the choriocapillaris (CC) (E), re-
spectively. En face projection of pvOCT for retinal vasculature (D) demon-
strates comparable microvascular visualization to FA (A). Inverting intensity
of minimum projection (F) of the pvOCT data segmented a depth slice of 35
μm thickness, located ∼50 μm below the RPE. This inverse image visualizes
large feeder vessels in the choroid, where there is usually non–phase-vari-
ance signal inside of these vessels shown by green arrowheads in C. The
color-coded images (G and H) are combined from retinal vessels (D, red), CC
(E, green), and deep choroidal vessels (F, blue). (Scale bars, 200 μm.)
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through video (Movie S2), ∼230 μm below the anterior surface
of the retina. The CC denoted by the yellow arrowhead in Fig.
2C is ∼36 μm in diameter. The vessels of Sattler’s layer (Fig.
2D), located between the CC and Haller’s layer (the outermost
layer in the choroid), include medium-sized arterioles and
venules ∼70–85 μm in diameter at the red arrows. Cross-sec-
tional views (see Fig. 5 A and B) were acquired at the location
identiﬁed by the yellow dashed line (Fig. 2D), illustrating depth
locations of retinal and choroidal circulation. The composite
image (Fig. 2E) accentuates the highly dense capillary plexus of
CC (Fig. 2C, green) visualized with the retinal circulation (Fig.
2B, red), available to exhibit lobular patterns of CC (Fig. S6 and
Movie S7). In addition, the superimposed image (Fig. 2F) of the
CC (Fig. 2C, green) and choroidal vessels of the intermediate
layer (Fig. 2D, magenta) demonstrates medium-sized vessel net-
works supplying the CC. Morphological features of these in vivo
results are analogous to the histological images by corrosion vas-
cular casts and scanning electron microscopy (14).
Abnormalities in the Choroidal Circulation: GA. Although current
clinical imaging modalities can deﬁne progression of GA in eyes
with AMD for large and well-established lesions, there is little
information available regarding changes in the CC in the early
stages of the disease (8). One of the reasons has been the limited
ability to study in vivo changes in CC in detail thus far. The
clinical images (Fig. 3 A–D) from the GA patient shown in Fig. 2
identify the atrophic regions at the fovea (3° inferior retina ec-
centricities) by different methods. The color (Fig. 3A) and red-
Fig. 2. Imaging of choriocapillaris of the peripheral
retina for a scanning area of 3 × 1.5 mm2 with ad-
ditional identiﬁcation of arterioles and venules in the
choroid. Color fundus photograph (A) zooming in the
region of the yellow dotted rectangle in the full-size
image (Fig. S5A). Maximum projection of pvOCT data
from retinal layers (B) and CC (C) and Sattler’s layer
(D). The yellow dashed line in D is shown in cross-
sectional views in Fig. 5 A–D. Segmented depths for
these images are positioned 9 μm underneath Bruch’s
membrane for the CC and 16 μm for Sattler’s layer.
The color-coded image (E) is combined from retinal
capillaries (B, red) and CC (C, green) as well as the
image (F) consisting of CC (C, green) and Sattler’s
layer (D, magenta). (Scale bars, 200 μm.)
Fig. 3. Small ﬁeld of view images (1.5 × 1.5 mm2) at the atrophic region of the patient with GA. Selected regions of color fundus (A), red-free (B), AF (C), and
the early venous stage of FA (D) images from the location identiﬁed in the green square (Fig. S5). The yellow dashed line in D is shown in cross-sectional views
in Fig. 6 E–H. En face projection images for retinal vasculature (E), vessels in the inner choroidal layer (F), and large choroidal vessels (G) from pvOCT data
(Movie S3). A composite image (H) of three depth layers (retina, red; inner choroid, green; deep choroid, blue). (Scale bars, 200 μm.)
14356 | www.pnas.org/cgi/doi/10.1073/pnas.1307315110 Kim et al.
free (Fig. 3B) photographs demonstrated higher reﬂectivity for
shorter wavelengths in the atrophic region due to enhanced
penetration of the light into the choroid. The fundus AF (Fig.
3C) depicted a well-deﬁned area lacking ﬂuorescence (dark
zone) corresponding to the area of GA (16). The early phase of
FA (Fig. 3D) shows a somewhat blurred outline of the deeper
larger choroidal vessels in the area of GA likely due to loss of the
overlying CC. The pvOCT images, however, show well-deﬁned
capillary networks in the retina (Fig. 3E) and the inner choroidal
layer (Fig. 3F) with focal disruption/loss of CC within the area of
GA. Here, segmentation of the inner choroidal layer was ∼6 μm
beneath the RPE from the volumetric ﬂy-through video (Movie
S3). Increased penetration of the infrared light source into the
choroid enabled the visualization of larger choroidal vessels (Fig.
3G) at the outer Haller’s layer without the use of the inversing
minimum projection method presented earlier. Here, the diame-
ter of the larger vessel is ∼168 μm at the red arrow. Furthermore,
the green dotted line (Fig. 3G), delineating deeper vasculature
areas from surrounding dimmer areas agrees with the atrophic
area from the clinical images (Fig. 3 A–C).
To demonstrate changes in the CC in the normal appearing
retina surrounding GA, we acquired a large ﬁeld of view OCT
scan (6° inferior retina eccentricities) covering atrophic and
healthy regions of the macula from the same GA patient. The
color fundus (Fig. 4A) and AF (Fig. 4B) images show two regions
of GA. An en face projection (Fig. 4E) of CC segmented ∼6 μm
underneath the RPE (Movie S4) indicated focal patches of CC
atrophic regions and were marked by green arrowheads. The
combined pseudocolor coded image of retinal vessels (Fig. 4D,
red) and CC (Fig. 4E, green) allows discrimination of remaining
and damaged regions of CC. The diameter of hexagonally arrayed
capillaries denoted by two red arrows is ∼24 μm. The estimated
size of the CC at the macula is comparable to measurements
taken from another subject at the same region (Fig. 1). The di-
ameter of these capillaries is expected to increase as the location
moves toward the peripheral retina, as is demonstrated by the
measurements of ∼40 μm shown in Fig. 2. This trend is in agree-
ment with previous histopathological studies (15).
Depth Locations of Vasculature in the Posterior Eye. Two-dimensional
clinical fundus images can, in general, classify atrophic AMD
according to optical reﬂectivity differences (8). A unique
feature of our noninvasive technique is that the pvOCT images
provide the depth of the vascular abnormalities and associated
structural changes. To evaluate the capabilities of OCT intensity
and pvOCT data in the identiﬁcation of vascular circulation
within B-scans, composite images of these two imaging methods
have been compared at normal (Fig. 5 A–D) and GA (Fig. 5 E–H)
regions. The OCT intensity cross-sectional scan (Fig. 5A) pro-
vides identiﬁcation of retinal and choroidal layers; larger retinal
and choroidal vessels can also be observed, indicated by the
orange arrowhead and the white arrow, respectively. Medium
diameter blood vessels, indicated by purple arrowheads (Fig.
5C) in Sattler’s layer, can be identiﬁed and are positioned be-
tween the CC and the outermost choroid layer. However, within
conventional OCT intensity images, it is challenging to separate
retinal and choroidal microcapillaries from neighboring bright
structures. Unlike the OCT intensity image, the combined B-
scan (Fig. 5B) with phase-variance processing emphasizes depth
locations of capillaries (red). The magniﬁed image (Fig. 5D)
demonstrates blood perfusion in the inner choroid layer where
green arrows denote phase-variance signals from the CC un-
derneath Bruch’s membrane. The averaged OCT B-scan (Fig. 5E)
shows loss of photoreceptor cells at the blue arrow in the fovea,
resulting in a central blind spot. Red arrows compare the deeper
OCT depth penetration region of the atrophy to the non-
enhanced beam penetration area. The composite image (Fig.
5F) with pvOCT indicates locations of vasculature and the
zoomed-in position (Fig. 5H) of the yellow dashed rectangle.
Discussion
Depth-resolved vascular imaging in the eye with pvOCT has
several advantages for clinical diagnostic and research settings,
particularly with regards to visualization and convenience. High-
resolution 3D microvascular imaging capabilities of pvOCT
allows for virtual segmentation of the retinal and choroidal
layers, providing opportunities to observe subtle changes in the
microvasculature during the progression and treatment of ocular
diseases. In addition, pvOCT is able to visualize vasculature in-
dependent of regional leakage due to contrast differences. With
this capability, vascular response to antiangiogenic therapeutics
can be directly visualized, even in the presence of leakage, which
might impact other angiography methods. The noninvasive
nature of this imaging method permits more frequent use than
Fig. 4. Identiﬁcation of abnormality in CC at edges
of GA for a scanning area of 3 × 1.5 mm2. Selected
regions of color fundus photograph (A), AF (B), and
an early phase of FA (C) from the location identiﬁed
by the purple dotted rectangle (Fig. S5). An en face
image (D) from pvOCT data shows ﬁne normal retinal
capillaries (yellow arrows) at the edge of GA, which
are not as well visualized with FA (C). A CC perfusion
map (E) from pvOCT illustrates small focal areas of CC
dropout near the inferior edge of GA, which corre-
lates with the areas of irregular choroidal ﬁlling on
FA (C). A color composite image (F) of retinal circu-
lation (D, red) and CC (E, green) from pvOCT. (Scale
bars, 200 μm.)
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clinical angiography techniques currently used. This creates
opportunities for monitoring long-term vascular disease pro-
gression as well as for early disease detection, an option that is
limited by the invasiveness of the injectable dyes used in clinical
angiography.
As mentioned previously, one of the limitations of this imaging
method is the shadow artifacts observed deep to the retinal vas-
culature. This type of artifact is a byproduct of pvOCT contrast,
which calculates the variance over time of phase changes for
scatterers in the retina and choroid. Because phase is dependent
on the optical path traveled by the imaging light, changes in phase
can be caused by positional changes of the scatterer or by changes
in the index of refraction of the optical path the light has traveled.
Below regions of major vasculature, it is difﬁcult for pvOCT to
differentiate between variations in scattering positions and var-
iances in the index of refraction of the region of ﬂow, which
creates the artifacts identiﬁed previously.
Within OCT imaging of the choroid, signal is noticeably absent
within the largest choroidal vessels (17). We suspect that fast ﬂow
rates of these vessels induce fringe washout of spectrometer-
based OCT signals and cause the signal to drop below the noise
level of the system. In that case, the loss of OCT intensity signal
within these blood vessels also creates a lack of phase-shift in-
formation and pvOCT signal (18). To address this issue, we have
applied a similar methodology to the visualization of choroidal
vessels by an inversed minimum projection view of the phase-
variance processed data segmented over Haller’s layer (Fig. 1F).
This study has demonstrated some of the capabilities of pvOCT
for microvascular imaging in the posterior eye, bringing the
potential for in vivo identiﬁcation of vascular degeneration and
atrophy in the choroid. These results establish that this modality
may provide an opportunity for diagnosing choroidal vascular
abnormalities, including those occurring in GA, and may po-
tentially be useful for studying changes in CC associated with
exudative AMD, before and after antiangiogenic therapy. This
noninvasive vasculature imaging technique is a software solution
that can be implemented in clinically available OCT systems
without any hardware modiﬁcation, which is beneﬁcial for trans-
lational research and further clinical applications. The pvOCT
method holds the potential to revolutionize the ﬁeld of choroidal
vascular diagnostics and treatment.
Methods
Human Subject Imaging. This research observed the tenets of the Declaration
of Helsinki. Written informed consent was obtained after all procedures were
fully explained, and before experimental measurements. The consent was
approved by the institutional review board at the University of California,
Davis School of Medicine.
Fig. 5. Depth-resolved image of capillaries in the retina and the choroid. A standard OCT cross-sectional scan (A) averaging three B-scans within a BM-scan
(multiple B-scans at the same position) and a composite image (B) of the OCT B-scan (gray) and pvOCT image (red). The retinal position of Fig. 5 A–D is
identiﬁed on the vertical yellow dashed line in Fig. 2D. Magniﬁed version of OCT intensity (C) and composite imaging (D) cropped from the location indicated
at the yellow dashed rectangles in A and B. An OCT B-scan (E) and a pvOCT red-coded image (F) of the patient with GA, with a retinal scan location as
identiﬁed on the horizontal yellow dashed line Fig. 3D. Cropped images (G and H) from the location of the yellow dashed rectangles in E and F . As indicated
by the blue arrow (Fig. 5H), the phase-variance signals by microcirculation disappeared underneath Bruch’s membrane due to CC atrophy, whereas motion
contrast signals by blood perfusion (remaining CC) exist in the region pointed by the yellow arrowhead. Volumetric imaging of color-coded B-scans from
above two datasets is included (Movies S5 and S6). Horizontal image size for A, B, E, and F: 1.5 mm. (Scale bars, 200 μm.)
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Fundus Photography. Color and red-free fundus photographs (50° ﬁeld of
view) were acquired with a Topcon (TRC-50IX) camera having resolution of
1,280 (horizontal, H) × 1,024 (vertical, V) pixels. The color photographs were
acquired from full red, green, blue (RGB) color imaging with white light il-
lumination from a xenon lamp. The red-free photographs were obtained
with a green ﬁlter to remove long wavelengths. For ﬂuorescein angiogra-
phy, sodium ﬂuorescein 10% in water (500 mg/5 mL) was injected in-
travenously using a 23- or 25-gauge needle, followed by a ﬂush of normal
saline. Either the TRC-50IX or the Spectralis (HRA + OCT, trademarked
product of Heidelberg Engineering) were used for FA imaging. The images
consisted of 1,536 (H) × 1,536 (V) pixels over 30° acquired at a 40-kHz
scanning rate with a confocal scanning laser ophthalmoscope (cSLO). A 488-
nm wavelength laser with 300 μW power excites the ﬂuorescein, together
with a barrier ﬁlter at 500 nm to separate the excitation and emission light.
ICGA imaging was obtained after i.v. injection of 25 mg in 5 mL of aqueous
diluent and then after ﬂushing the line with 5 mL normal saline i.v. A diode
laser at 790 nm and an 830-nm ﬁlter were used for excitation of ICG and
blocking the excitation light, respectively. In addition, AF acquired endog-
enous ﬂuorescence reﬂectance imaging by excitation from the 488 nm
light. ICGA and AF images were acquired with the Spectralis HRA + OCT.
All these clinical images were taken with fully dilated pupils. These pro-
cedures, imaging systems, and contrast dyes are approved by the Food and
Drug Administration.
OCT Imaging. A schematic of the OCT system is shown in Fig. 6. The light
source is a superluminescent diode (D855; Superlum Diodes) with a center
wavelength of 855 nm, bandwidth of 75 nm, allowing axial resolution of
4.5 μm in the retina (refractive index, n = 1.38). The transverse resolution at
the retina is estimated at 10–15 μm depending on the subject’s ocular aber-
rations. The measured light power at the pupil is 700 μW, which is below the
safety limit of the American National Standards Institute (19) and the maxi-
mum sensitivity of the system is ∼100 dB. The ﬁxation target was viewed
through a dichroic beamsplitter. A ﬁber coupler (AC Photonics) with an 80/20
splitting ratio sends 20% of the input light to the sample arm and 80% to the
reference arm containing glass matched to the dispersion of water. An isolator
prevents back reﬂection of the light to the source. The galvanometer mirrors
(6200H; Cambridge Technology) are used for X–Y scanning. A purpose-built
spectrometer consisted of a 12-bit line scan camera (spL4096, 140 km; Basler
AG) with 4,096 pixels, a 150-mm objective lens, and a 1,200 L/mm diffraction
grating (20). The imaging speed in this study was 125 KHz using 2,048 active
pixels. The rapid-speed frame grabber (PCIe-1429; National Instruments)
acquires interference fringe patterns from the camera, and custom-made
software written in LabVIEW (National Instruments) supports standard Fd-OCT
processing including spectral shaping (21), zero padding (22), and dispersion
compensation (23). Imaging acquisition time for retinal area scans of 1.5 × 1.5
mm2 and 3 × 3 mm2 was 3.8 s and the 1.5 × 3 mm2 and 3 × 1.5 mm2 scans were
acquired in 6.9 s. Image sampling density between successive A-scans (axial
scans) and BM-scans is ∼4 μm for 1.5 × 1.5 mm2 and 1.5 × 3 mm2 scan patterns,
and ∼8 μm for the 3 × 3 mm2 scan pattern. A forehead rest and a bite bar were
used to reduce head motion, while a liquid crystal display screen provided
a ﬁxation target to reduce eye motion artifacts. The eye pupil was not dilated
for pvOCT imaging. Phase-variance processing (24, 25) of acquired volumetric
data from human subjects is described in Supporting Information.
ACKNOWLEDGMENTS. We thank R. H. Grubbs (Department of Chemistry,
California Institute of Technology) for helpful discussions and support and
S. Garcia (Vision Science and Advanced Retinal Imaging Laboratory, University
of California, Davis Medical Center) for help with phase-variance optical
coherence tomography data acquisition and acquiring fundus photographs.
This research was funded in part by National Eye Institute Grant EY014743 (to
J.S.W.), Research to Prevent Blindness (J.S.W., S.S.P., and L.S.M.), the Beckman
Institute (S.E.F.), the That Man May See Foundation (D.M.S.), and Howard
Hughes Medical Institute Med-into-Grad Initiative 56006769 (to D.Y.K.).
1. Forte R, et al. (2012) Multimodal imaging of dry age-related macular degeneration.
Acta Ophthalmol (Copenh) 90(4):e281–e287.
2. Querques L, Querques G, Forte R, Souied EH (2012) Microperimetric correlations of
autoﬂuorescence and optical coherence tomography imaging in dry age-related
macular degeneration. Am J Ophthalmol 153(6):1110–1115.
3. Friedman DS, et al.; Eye Diseases Prevalence Research Group (2004) Prevalence of age-
related macular degeneration in the United States. Arch Ophthalmol 122(4):564–572.
4. Bird AC, et al.; International ARM Epidemiological Study Group (1995) An international
classiﬁcation and grading system for age-relatedmaculopathy and age-related macular
degeneration. Surv Ophthalmol 39(5):367–374.
5. McLeod DS, et al. (2002) Quantifying changes in RPE and choroidal vasculature in eyes
with age-related macular degeneration. Invest Ophthalmol Vis Sci 43(6):1986–1993.
6. Sunness JS (1999) The natural history of geographic atrophy, the advanced atrophic
form of age-related macular degeneration. Mol Vis 5:25.
7. Holz FG, Bellman C, Staudt S, Schütt F, Völcker HE (2001) Fundus autoﬂuorescence
and development of geographic atrophy in age-related macular degeneration. Invest
Ophthalmol Vis Sci 42(5):1051–1056.
8. Brader HS, Ying GS, Martin ER, Maguire MG; Complications of Age-Related Macular
Degeneration Prevention Trial-CAPT Research Group (2011) New grading criteria al-
low for earlier detection of geographic atrophy in clinical trials. Invest Ophthalmol Vis
Sci 52(12):9218–9225.
9. Huang D, et al. (1991) Optical coherence tomography. Science 254(5035):1178–1181.
10. Wojtkowski M, Leitgeb R, Kowalczyk A, Bajraszewski T, Fercher AF (2002) In vivo
human retinal imaging by Fourier domain optical coherence tomography. J Biomed
Opt 7(3):457–463.
11. Fleckenstein M, et al. (2008) High-resolution spectral domain-OCT imaging in geo-
graphic atrophy associated with age-related macular degeneration. Invest Ophthalmol
Vis Sci 49(9):4137–4144.
12. Spaide RF, Koizumi H, Pozzoni MC (2008) Enhanced depth imaging spectral-domain
optical coherence tomography. Am J Ophthalmol 146(4):496–500.
13. Imamura Y, Fujiwara T, Margolis R, Spaide RF (2009) Enhanced depth imaging optical
coherence tomography of the choroid in central serous chorioretinopathy. Retina
29(10):1469–1473.
14. Yoneya S, Tso MO (1987) Angioarchitecture of the human choroid. Arch Ophthalmol
105(5):681–687.
15. Olver JM (1990) Functional anatomy of the choroidal circulation: Methyl methacrylate
casting of human choroid. Eye (Lond) 4(Pt 2):262–272.
16. Delori FC, et al. (1995) In vivo ﬂuorescence of the ocular fundus exhibits retinal pig-
ment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci 36(3):718–729.
17. Povazay B, et al. (2009) Wide-ﬁeld optical coherence tomography of the choroid in
vivo. Invest Ophthalmol Vis Sci 50(4):1856–1863.
18. Hendargo HC, McNabb RP, Dhalla AH, Shepherd N, Izatt JA (2011) Doppler velocity
detection limitations in spectrometer-based versus swept-source optical coherence
tomography. Biomed Opt Express 2(8):2175–2188.
19. Delori FC, Webb RH, Sliney DH; American National Standards Institute (2007) Maxi-
mum permissible exposures for ocular safety (ANSI 2000), with emphasis on oph-
thalmic devices. J Opt Soc Am A Opt Image Sci Vis 24(5):1250–1265.
20. Kim DY, et al. (2011) In vivo volumetric imaging of human retinal circulation with
phase-variance optical coherence tomography. Biomed Opt Express 2(6):1504–1513.
21. Nassif N, et al. (2004) In vivo high-resolution video-rate spectral-domain optical co-
herence tomography of the human retina and optic nerve.Opt Express 12(3):367–376.
22. Zawadzki RJ, et al. (2005) Adaptive-optics optical coherence tomography for high-
resolution and high-speed 3D retinal in vivo imaging. Opt Express 13(21):8532–8546.
23. Wojtkowski M, et al. (2004) Ultrahigh-resolution, high-speed, Fourier domain optical
coherence tomography and methods for dispersion compensation. Opt Express
12(11):2404–2422.
24. Fingler J, Zawadzki RJ, Werner JS, Schwartz D, Fraser SE (2009) Volumetric micro-
vascular imaging of human retina using optical coherence tomography with a novel
motion contrast technique. Opt Express 17(24):22190–22200.
25. Kim DY, et al. (2012) Noninvasive imaging of the foveal avascular zone with high-speed,
phase-variance optical coherence tomography. Invest Ophthalmol Vis Sci 53(1):85–92.
Fig. 6. Schematic of the OCT system. A ﬁber-based Michelson interferometer
was used with an infrared light source having 855-nm central wavelength.
The power of the collimated light at the pupil of the eye is 700 μW, below the
safety limit of the American National Standards Institute. The light is focused
onto the posterior eye, and the back-reﬂected light from the sample and the
reference mirror are combined in the spectrometer portion of the in-
terferometer, which uses a line-scan camera to acquire spectral fringes of the
combined light. The Fourier transform of a single spectral fringe pattern
generates depth information of a single point, both an intensity proﬁle (axial
scan or A-scan) and its phase proﬁle. The X–Y scanner permits acquisition of
3D datasets over deﬁned patches of retina.
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